Sigma-1R Protects Retinal Ganglion Cells in Optic Nerve Crush Model for Glaucoma

Linya Li1, Shaoqing He2, Yang Liu1,2

  • 1Department of Pharmacology and Neuroscience University of North Texas Health Science Center, Fort Worth, Texas, United States.

Abstract

Insights

The Sigma-1R (σ-1r) receptor protects retinal ganglion cells (RGCs) after optic nerve crush (ONC). Activating or increasing σ-1r expression preserves RGCs by reducing apoptosis.

Area of Science:

  • Neuroscience
  • Ophthalmology
  • Cell Biology

Background:

  • Retinal ganglion cells (RGCs) are crucial for vision.
  • Optic nerve crush (ONC) is a common model for studying optic nerve injury and RGC degeneration.
  • The Sigma-1R (σ-1r) is a unique intracellular chaperone protein implicated in various cellular functions, including neuroprotection.

Purpose of the Study:

  • To investigate the neuroprotective effects of the Sigma-1R (σ-1r) on retinal ganglion cell (RGC) survival after optic nerve crush (ONC).
  • To elucidate the signaling mechanisms underlying σ-1r-mediated protection in the context of ONC.

Main Methods:

  • Optic nerve crush (ONC) was induced in wild-type (WT) and σ-1r knockout (K/O) mice.
  • σ-1r expression was increased using AAV2-σ-1r vectors, and σ-1r activity was modulated using the agonist pentazocine.
  • RGC survival and function were assessed via cell counting and pattern electroretinography (PERG).
  • Apoptotic markers (p-c-Jun, c-Jun, Caspase-3) were analyzed using immunohistochemistry and Western blotting.

Main Results:

  • ONC led to significant RGC loss and functional decline in both WT and σ-1r K/O mice, with greater severity in σ-1r K/O mice.
  • Transgenic overexpression or agonist-induced activation of σ-1r significantly increased RGC counts and improved function post-ONC.
  • Pentazocine treatment mitigated the time-dependent increases in apoptotic markers (c-Jun, p-c-Jun, Caspase-3) following ONC.

Conclusions:

  • The apoptotic pathway plays a critical role in RGC loss following ONC.
  • Sigma-1R (σ-1r) activation or increased expression confers significant neuroprotection to RGCs after optic nerve injury.
  • Targeting σ-1r represents a promising therapeutic strategy for preserving vision in conditions involving optic nerve damage.

Related Concept Videos